一个尺寸不适合所有:精确组合FGFR4驱动的癌症
Emmy D G Fleuren1,2,3
1Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW 2031, Australia.
Frontiers in bioscience (Landmark edition)
|October 11, 2025
概括
瘤性纤维细胞生长因子受体4 (FGFR4) 信号驱动癌症,但出现了耐药性. 这项研究揭示了适应性旁路反应和细胞特异性药物组合,以克服FGFR4驱动癌症的治疗抵抗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 瘤性纤维细胞生长因子受体4 (FGFR4) 信号传递是各种癌症的关键治疗标.
- 治疗耐药性,通常是由适应性旁路反应驱动的,均地限制了治疗疗效.
- 了解动态激酶信号网络重新布线对于克服阻力至关重要.
研究的目的:
- 探索FGFR4驱动癌症中的自适应信号格局.
- 确定细胞上下文依赖的组合策略来克服治疗耐药性.
- 为个性化癌症治疗提供分子层面的理解.
主要方法:
- 研究了适应信号网络的重新布线,以应对FGFR4抑制.
- 在不同癌症类型中分析了对比的FGFR4信号通路组件和网络行为.
- 采用了技术上优雅和生物学上的实验方法.
主要成果:
- 确定了适应性旁路反应是对FGFR4向疗法的抗性的一个关键机制.
- 揭示了信号网络重编程中的细胞上下文依赖的变异.
- 证明特定的组合药物策略可以克服适应性耐药性.
结论:
- 向瘤性FGFR4信号需要考虑适应性绕道反应的策略.
- 细胞环境特定的组合疗法对于实现持续的瘤反应至关重要.
- 这项研究为FGFR4驱动癌症的精准医学提供了框架.
更多相关视频
05:29A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
3.2K
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
12.2K
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combinatorial Gene Control
9.5K
Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.5K
Conservative Site-specific Recombination and Phase Variation
6.6K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.6K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
